Progressive segregation of unmyelinated axons in peripheral nerves, myelin alterations in the CNS, and cyst formation in the kidneys of myelin and lymphocyte protein-overexpressing mice

被引:25
作者
Frank, M
Atanasoski, S
Sancho, S
Magyar, JP
Rülicke, RT
Schwab, ME
Suter, U [1 ]
机构
[1] ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland
[2] Univ Zurich, Brain Res Inst, Dept Neuromorphol, Zurich, Switzerland
[3] Univ Zurich Hosp, Cent Biol Lab, CH-8091 Zurich, Switzerland
关键词
Schwann cell; oligodendrocyte; membrane microdomain; protein transport;
D O I
10.1046/j.1471-4159.2000.0751927.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myelin and lymphocyte protein (MAL) is a putative tetraspan proteolipid that is highly expressed by Schwann cells and oligodendrocytes as a component of compact myelin. Outside of the nervous system, MAL is found in apical membranes of epithelial cells, mainly in the kidney and stomach. Because MAL is associated with glycosphingolipids, it is thought to be involved in the organization, transport, and maintenance of glycosphingolipid-enriched membrane microdomains. In this report, we describe the generation and analysis of transgenic mice with increased MAL gene dosage. Immunohistochemical analysis revealed that the localization of MAL overexpression in the transgenic animals corresponded closely to the MAL expression pattern observed in wildtype animals, indicating correct spatial regulation of the transgene. Phenotypically, MAL overexpression led to progressive dissociation of unmyelinated axons from bundles in the PNS, a tendency to hypomyelination and aberrant myelin formation in the CNS, and the formation of large cysts in the tubular region of the kidney. Thus, increased expression of MAL appears to be deleterious to membranous structures in the affected tissues, indicating a requirement for tight control of endogenous MAL expression in Schwann cells, oligodendrocytes, and kidney epithelial cells.
引用
收藏
页码:1927 / 1939
页数:13
相关论文
共 52 条
[41]   A transgenic rat model of Charcot-Marie-Tooth disease [J].
Sereda, M ;
Griffiths, I ;
Puhlhofer, A ;
Stewart, H ;
Rossner, MJ ;
Zimmermann, F ;
Magyar, JP ;
Schneider, A ;
Hund, E ;
Meinck, HM ;
Suter, U ;
Nave, KA .
NEURON, 1996, 16 (05) :1049-1060
[42]  
Shayman JA, 1996, J AM SOC NEPHROL, V7, P171
[43]   STRUCTURE AND FUNCTION OF RENAL GLYCOSPHINGOLIPIDS [J].
SHAYMAN, JA ;
RADIN, NS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :F291-F302
[44]  
SNIPES GJ, 1995, J ANAT, V186, P483
[45]   Myelin glycolipids and their functions [J].
Stoffel, W ;
Bosio, A .
CURRENT OPINION IN NEUROBIOLOGY, 1997, 7 (05) :654-661
[46]   BIOLOGY AND GENETICS OF HEREDITARY MOTOR AND SENSORY NEUROPATHIES [J].
SUTER, U ;
SNIPES, GJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1995, 18 :45-75
[47]   KROX-20 CONTROLS MYELINATION IN THE PERIPHERAL NERVOUS-SYSTEM [J].
TOPILKO, P ;
SCHNEIDERMAUNOURY, S ;
LEVI, G ;
BARONVANEVERCOOREN, A ;
CHENNOUFI, AB ;
SEITANIDOU, T ;
BABINET, C ;
CHARNAY, P .
NATURE, 1994, 371 (6500) :796-799
[48]   A tandem array of Sp-1 sites and a reverse initiator element are both required for synergistic transcriptional activation of the T-cell-specific MAL gene [J].
Tugores, A ;
Rubio, T ;
Rancano, C ;
Alonso, MA .
DNA AND CELL BIOLOGY, 1997, 16 (03) :245-255
[49]   Clinical phenotypes of different MPZ (P-0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination [J].
Warner, LE ;
Hilz, MJ ;
Appel, SH ;
Killian, JM ;
Kolodny, EH ;
Karpati, G ;
Carpenter, S ;
Watters, GV ;
Wheeler, C ;
Witt, D ;
Bodell, A ;
Nelis, E ;
Van Broeckhoven, C ;
Lupski, JR .
NEURON, 1996, 17 (03) :451-460
[50]   Mouse models of myelin diseases [J].
Werner, H ;
Jung, M ;
Klugmann, M ;
Sereda, M ;
Griffiths, IR ;
Nave, KA .
BRAIN PATHOLOGY, 1998, 8 (04) :771-793